NCT03739788View on ClinicalTrials.gov

An Investigational Study to Evaluate Experimental Medication BMS-986165 Given as a Tablet and Solution in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 5, 2018

Primary Completion Date

February 11, 2019

Study Completion Date

February 11, 2019

Conditions
Healthy Participants
Interventions
DRUG

BMS-986165

Oral administration of tablet and 15-minute intravenous BMS-986165 solution for infusion

Trial Locations (1)

NG11 6JS

Quotient Sciences, Nottingham

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY